OXB's lentiviral vector manufacturing technology to support Boehringer Ingelheim's newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis Oxford, UK – 20 February 2025: ...
Viral vectors are critical components of cell and gene therapy products, and they require extensive characterization to ensure their safe and effective use. Capillary electrophoresis is a proven ...
The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is becoming of higher importance. Lentiviruses are enveloped viruses that are rather ...
SAN DIEGO, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today ...
PARIS--(BUSINESS WIRE)--TheraVectys, a biotechnology company that designs and develops lentiviral vector-based vaccines and immunotherapies against infectious agents and cancers, announces that the ...
This agreement supports the growing demand for lentivector-based gene therapies, immunotherapies and vaccines PARIS and LYON, France, April 16, 2019 /PRNewswire/ -- Novasep, a leading supplier of ...
Technologies used for cell and gene therapy development have come a long way but there are still important challenges associated with lentivirus manufacture. GMP plasmids account for a substantial ...
AMSBIO has introduced a range of ready-to-use human and mouse lentivirus products for miRNA and anti-miRNA expression (miRNA inhibition). Lentiviral expression vectors are the most effective vehicles ...
Lentigen and Dharmacon, a unit of Fisher Biosciences, entered into a multiyear collaboration to develop and manufacture lentiviral expression reagents to deliver short hairpin RNA (shRNA) expression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results